Regulators delay decision on Barr's 'morning after' pill (R


Reuters - U.S. officials deferred ruling on
over-the-counter sales of Barr Pharmaceuticals Inc.'s
"morning-after" contraceptive on Friday, sparking charges that
repeated delays were motivated by politics rather than science.

Read more...